|
Pre-MFDC
|
Post-MFDC
|
Sign.
|
---|
2007 (n = 21)
|
2008 (n = 20)
|
2010 (n = 24)
|
2013 (n = 24)
|
ANOVA
|
---|
Age Mean(SD)
|
66
|
(11)
|
66
|
(13)
|
63
|
(13)
|
64
|
(9)
|
.640
|
|
Chi2
|
Gender
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
.680
|
Male
|
14
|
67
|
13
|
65
|
18
|
75
|
14
|
58
| |
Tumour localization
|
.303
|
Lip
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
100
| |
Oral cavity
|
8
|
38
|
11
|
55
|
17
|
71
|
9
|
38
| |
Tongue (C01, C02)
|
3
| |
2
| |
6
| |
1
| | |
Gums (C03)
|
1
| |
3
| |
2
| |
0
| | |
Floor of mouth (C04)
|
3
| |
4
| |
4
| |
6
| | |
Oral cavity, unspec.
|
1
| |
2
| |
5
| |
2
| | |
(C00, C05, C06, C14)
|
Major salivary glands (C07, C08)
|
1
|
5
|
0
|
0
|
0
|
0
|
0
|
0
| |
Oropharynx (C09,C10)
|
2
|
10
|
2
|
10
|
1
|
4
|
4
|
17
| |
Nasopharynx (C11)
|
1
|
5
|
2
|
10
|
1
|
4
|
1
|
4
| |
Nasal Cavity (C30)
|
0
| |
0
|
0
|
1
|
4
|
1
|
4
| |
Hypopharynx (C12, C13)
|
3
|
14
|
1
|
5
|
0
|
0
|
5
|
21
| |
Larynx (C32)
|
6
|
29
|
4
|
20
|
4
|
17
|
2
|
8
| |
Tumour size
|
.522
|
T1
|
9
|
43
|
8
|
40
|
10
|
42
|
4
|
17
| |
T2
|
5
|
24
|
4
|
20
|
5
|
21
|
6
|
26
| |
T3
|
3
|
14
|
2
|
10
|
3
|
13
|
2
|
8
| |
T4
|
4
|
19
|
6
|
30
|
5
|
21
|
12
|
50
| |
Tx
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
| |
- In bold main patient characteristics of the dataset (age, gender, tumour localization and size)